<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-7J24EPJ3</identifier><date>2018</date><creator>Matos, Erika</creator><relation>documents/doc/7/URN_NBN_SI_doc-7J24EPJ3_001.pdf</relation><relation>documents/doc/7/URN_NBN_SI_doc-7J24EPJ3_001.txt</relation><format format_type="issue">1</format><format format_type="volume">22</format><format format_type="type">article</format><format format_type="extent">str. 38-41</format><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID_HOST">2991739</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-7J24EPJ3</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="eng">adaptive trial</subject><subject language_type_id="eng">clinical trial phases</subject><subject language_type_id="eng">clinical trials</subject><subject language_type_id="slv">faze kliničnih raziskav</subject><subject language_type_id="slv">klinične raziskave</subject><subject language_type_id="slv">na dokazih temelječe zdravljenje</subject><subject language_type_id="slv">tipi raziskav</subject><title>Clinical trials in oncology</title><title>Klinične raziskave v onkologiji</title></Record>